Metabolomics techniques in nanotoxicology studies

Methods in Molecular Biology

Volumn 926, Issue , 2012, Pages 141-156

  Schnackenberg, Laura K ^a   Sun, Jinchun ^a   Beger, Richard D ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Liquid chromatography mass spectrometry (LC MS); Metabolic profiling; Metabolomics; Nanoparticles; Nanotoxicology; Nuclear magnetic resonance spectroscopy (NMR)

Indexed keywords

2 OXOGLUTARIC ACID; ACETIC ACID; ALANINE AMINOTRANSFERASE; CITRIC ACID; COPPER NANOPARTICLE; CREATININE; LACTIC ACID; NANOMATERIAL; NANOPARTICLE; TAURINE;

ANALYTIC METHOD; ARTICLE; BIOSENSOR; CELL DAMAGE; CELL STRESS; CHEMOMETRICS; DATA ANALYSIS; FOURIER TRANSFORM MASS SPECTROMETRY; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NANOTOXICOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; SOLID STATE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 84934437253     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-2-1_10     Document Type: Article

References (81)

1. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444:267-269
2. Meng H, Xia T, George S, Nel AE (2009) A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 3:1620-1627
3. Xia T, Li N, Nel AE (2009) Potential health impact of nanoparticles. Annu Rev Public Health 30:137-150
4. Borm PJ (2002) Particle toxicology: from coal mining to nanotechnology. Inhal Toxicol 14:311-324
5. Borm PJ, Kreyling W (2004) Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 4:521-531
6. Oberdorster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89-105
7. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF (2010) Metalbased nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:544-568
8. Kagan VE, Bayir H, Shvedova AA (2005) Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 1:313-316
9. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622-627
10. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultra fine particles. Environ Health Perspect 113:823-839
11. Chithrani BD, Chan WC (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542-1550
12. Fiehn O (2002) Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 48:155-171
13. Nicholson JK, Lindon JC, Holmes E (1999) Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181-1189
14. Ebbels TM, Keun HC, Beckonert OP, Bollard ME, Lindon JC, Holmes E, Nicholson JK (2007) Prediction and classi fication of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J Proteome Res 6:4407-4422
15. Lindon JC, Keun H, Ebbels TMD, Pearce JMT, Holmes E, Nicholson JK (2005) The consortium for metabonomic toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6:691-699
16. Nicholson J, Keun H, Ebbels T (2007) COMET and the challenge of drug safety screening. J Proteome Res 6:4098-4099
17. Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, Braden TK (2000) Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57:326-337
18. Fujita K, Morimoto Y, Endoh S, Uchida K, Fukui H, Ogami A, Tanaka I, Horie M, Yoshida Y, Iwahashi H, Nakanishi J (2010) Identi fication of potential biomarkers from gene expression pro files in rat lungs intratracheally instilled with C(60) fullerenes. Toxicology 274:34-41
19. Tsou TC, Yeh SC, Tsai FY, Lin HJ, Cheng TJ, Chao HR, Tai LA (2010) Zinc oxide particles induce in flammatory responses in vascular endothelial cells via NF-kappaB signaling. J Hazard Mater 183:182-188
20. Semete B, Booysen LI, Kalombo L, Venter JD, Katata L, Ramalapa B, Verschoor JA, Swai H (2010) In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol 249:158-165
21. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF (2010) Nanoparticle-induced unfolding offibrinogen promotes Mac-1 receptor activation and in flammation. Nat Nanotechnol 6:39-44
22. Marquis BJ, Love SA, Braun KL, Haynes CL (2009) Analytical methods to assess nanoparticle toxicity. Analyst 134:425-439
23. Barnes CA, Elsaesser A, Arkusz J, Smok A, Palus J, Lesniak A, Salvati A, Hanrahan JP, Jong WH, Dziubaltowska E, Stepnik M, Rydzynski K, McKerr G, Lynch I, Dawson KA, Howard CV (2008) Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett 8:3069-3074
24. Colognato R, Bonelli A, Ponti J, Farina M, Bergamaschi E, Sabbioni E, Migliore L (2008) Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 23:377-382
25. Jacobsen NR, Pojana G, White P, Moller P, Cohn CA, Korsholm KS, Vogel U, Marcomini A, Loft S, Wallin H (2008) Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Mutatrade markMouse lung epithelial cells. Environ Mol Mutagen 49:476-487
26. Kang SJ, Kim BM, Lee YJ, Chung HW (2008) Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ Mol Mutagen 49: 399-405
27. Karlsson HL, Cronholm P, Gustafsson J, Moller L (2008) Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726-1732
28. Kisin ER, Murray AR, Keane MJ, Shi XC, Schwegler-Berry D, Gorelik O, Arepalli S, Castranova V, Wallace WE, Kagan VE, Shvedova AA (2007) Single-walled carbon nanotubes: geno-and cytotoxic effects in lung fibroblast V79 cells. J Toxicol Environ Health A 70:2071-2079
29. Mroz P, Pawlak A, Satti M, Lee H, Wharton T, Gali H, Sarna T, Hamblin MR (2007) Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus Type II photochemical mechanism. Free Radic Biol Med 43:711-719
30. Choi O, Hu Z (2008) Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 42:4583-4588
31. Clarke SJ, Hollmann CA, Zhang Z, Suffern D, Bradforth SE, Dimitrijevic NM, Minarik WG, Nadeau JL (2006) Photophysics of dopaminemodi fied quantum dots and effects on biological systems. Nat Mater 5:409-417
32. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, Dramicanin M, Harhaji L, Raicevic N, Nikolic Z, Trajkovic V (2006) Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 91:173-183
33. Lee KJ, Nallathamby PD, Browning LM, Osgood CJ, Xu XH (2007) In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebra fish embryos. ACS Nano 1:133-143
34. Lin W, Huang YW, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217:252-259
35. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B (2006) Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346-4352
36. Pulskamp K, Diabate S, Krug HF (2007) Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168:58-74
37. Sayes CM, Gobin AM, Ausman KD, Mendez J, West JL, Colvin VL (2005) Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 26:7587-7595
38. Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai LM, Hussain SM (2008) Can silver nanoparticles be useful as potential biological labels? Nanotechnology 19:235104, 13 pp
39. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21:10644-10654
40. Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, Stark WJ, Bruinink A (2007) The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett 168:121-131
41. Cellar NA, Burns ST, Meiners JC, Chen H, Kennedy RT (2005) Micro fluidic chip for lowflow push-pull perfusion sampling in vivo with on-line analysis of amino acids. Anal Chem 77:7067-7073
42. Hogan BL, Lunte SM, Stobaugh JF, Lunte CE (1994) On-line coupling of in vivo microdialysis sampling with capillary electrophoresis. Anal Chem 66:596-602
43. Sandlin ZD, Shou M, Shackman JG, Kennedy RT (2005) Micro fluidic electrophoresis chip coupled to microdialysis for in vivo monitoring of amino acid neurotransmitters. Anal Chem 77:7702-7708
44. Zhou SY, Zuo H, Stobaugh JF, Lunte CE, Lunte SM (1995) Continuous in vivo monitoring of amino acid neurotransmitters by microdialysis sampling with on-line derivatization and capillary electrophoresis separation. Anal Chem 67:594-599
45. Aragona BJ, Cleaveland NA, Stuber GD, Day JJ, Carelli RM, Wightman RM (2008) Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci 28: 8821-8831
46. Cheer JF, Aragona BJ, Heien ML, Seipel AT, Carelli RM, Wightman RM (2007) Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54: 237-244
47. Ewing AG, Bigelow JC, Wightman RM (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221:169-171
48. Dunn WB, Ellis DI (2005) Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 24:285-294
49. Lenz EM, Wilson ID (2007) Analytical strategies in metabonomics. J Proteome Res 6:443-458
50. Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809-822
51. Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J (2005) A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130: 844-849
52. Plumb RS, Johnson KA, Rainville P, Shockcor JP, Williams R, Granger JH, Wilson ID (2006) The detection of phenotypic differences in the metabolic plasma pro file of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 20:2800-2806
53. Plumb RS, Jones MD, Rainville PD, Nicholson JK (2008) A rapid simple approach to screening pharmaceutical products using ultra-performance LC coupled to time-of-flight mass spectrometry and pattern recognition. J Chromatogr Sci 46:193-198
54. Plumb RS, Rainville PD, Potts WB 3rd, Johnson KA, Gika E, Wilson ID (2009) Application of ultra performance liquid chromatography-mass spectrometry to pro filing rat and dog bile. J Proteome Res 8:2495-2500
55. Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS (2005) High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway pro filing in functional genomic studies. J Proteome Res 4:591-598
56. Yang J, Xu G, Zheng Y, Kong H, Wang C, Zhao X, Pang T (2005) Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 1084:214-221
57. Burnum KE, Frappier SL, Caprioli RM (2008) Matrix-assisted laser desorption/ionization imaging mass spectrometry for the investigation of proteins and peptides. Annu Rev Anal Chem (Palo Alto Calif) 1:689-705
58. Dumas M-E, Maibaum EC, Teague C, Ueshima H, Zhou B, Lindon JC, Nicholson JK, Stamler J, Elliott P, Chang Q, Holmes E (2006) Assessment of analytical reproducibility of 1 H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal Chem 78: 2199-2208
59. Keun HC, Ebbels TMD, Antti H, Bollard ME, Beckonert O, Schlotterbeck G, Senn H, Niederhauser U, Holmes E, Lindon JC, Nicholson JK (2002) Analytical reproducibility in 1 H NMR-based metabonomic urinalysis. Chem Res Toxicol 15:1380-1386
60. Deming SN (1986) Chemometrics: an overview. Clin Chem 32:1702-1706
61. Lavine B, Workman J (2008) Chemometrics. Anal Chem 80:4519-4531
62. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E (2005) NMR-based metabonomic approaches for evaluating physiological in fluences on bio fluid composition. NMR Biomed 18:143-162
63. Crockford DJ, Keun HC, Smith LM, Holmes E, Nicholson JK (2005) Curve-fitting method for direcct quantitation of compounds in complex biological mixtures using 1 H NMR: application in metabonomic toxicology studies. Anal Chem 77:4556-4562
64. Schnackenberg LK, Sun J, Espandiari P, Holland RD, Hanig J, Beger RD (2007) Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague Dawley rats and effects of data normalization methods on statistical and quantitative analysis. BMC Bioinformatics 8(Suppl 7):S3
65. Sysi-Aho M, Katajamaa M, Yetukuri L, Oresic M (2007) Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics 8:93
66. Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, Zhang H, Drexler DM (2009) Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 877:547-552
67. Bertram HC, Malmendal A, Petersen BO, Madsen JC, Pedersen H, Nielsen NC, Hoppe C, Molgaard C, Michaelsen KF, Duus JO (2007) Effect of magnetic field strength on NMR-based metabonomic human urine data. Comparative study of 250, 400, 500, and 800 MHz. Anal Chem 79:7110-7115
68. Chen P, Liu J (2007) Metabonomics and diabetes mellitus. Adv Ther 24:1036-1045
69. Pan Z, Gu H, Talaty N, Chen H, Shanaiah N, Hainline BE, Cooks RG, Raftery D (2007) Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal Bioanal Chem 387:539-549
70. Wagner S, Scholz K, Donegan M, Burton L, Wingate J, Volkel W (2006) Metabonomics and biomarker discovery: LC-MS metabolic pro filing and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal Chem 78:1296-1305
71. Wold S, Sjostrom M (1998) Chemometrics, present and future success. Chemometr Intell Lab Syst 44:3-14
72. Keun HC, Ebbels TMD, Bollard ME, Beckonert O, Antti H, Holmes E, Lindon JC, Nicholson JK (2004) Geometric trajectory analysis of metabolic responses to toxicity can de fine treatment speci fic pro files. Chem Res Toxicol 17:578-587
73. Lu X, Tian Y, Zhao Q, Jin T, Xiao S, Fan X (2011) Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 22:055101, 16 pp
74. Cao Q, Zhang S, Dong C, Song W (2007) Pulmonary responses to fine particles: differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol Lett 171: 126-137
75. Cho WS, Choi M, Han BS, Cho M, Oh J, Park K, Kim SJ, Kim SH, Jeong J (2007) In flammatory mediators induced by intratracheal instillation of ultra fine amorphous silica particles. Toxicol Lett 175:24-33
76. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009) Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 72: 496-501
77. Tang M, Zhang T, Xue Y, Wang S, Huang M, Yang Y, Lu M, Lei H, Kong L, Yuepu P (2010) Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. J Nanosci Nanotechnol 10:8575-8583
78. Hauck TS, Ghazani AA, Chan WC (2008) Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4:153-159
79. Zhang T, Stilwell JL, Gerion D, Ding L, Elboudwarej O, Cooke PA, Gray JW, Alivisatos AP, Chen FF (2006) Cellular effect of high doses of silica-coated quantum dot pro filed with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 6:800-808
80. Fowler BA, Conner EA, Yamauchi H (2008) Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materials. Toxicol Appl Pharmacol 233:110-115
81. Yang B, Wang Q, Lei R, Wu C, Shi C, Yuan Y, Wang Y, Luo Y, Hu Z, Ma H, Liao M (2010) Systems toxicology used in nanotoxicology: mechanistic insights into the hepatotoxicity of nano-copper particles from toxicogenomics. J Nanosci Nanotechnol 10:8527-8537